Rankings
▼
Calendar
EVAX Q4 2024 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena
EVAX
Evaxion Biotech A/S
$20M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$122,000
+67.1% YoY
Gross Profit
$122,000
100.0% margin
Operating Income
-$4M
-3298.4% margin
Net Income
-$4M
-2974.6% margin
EPS (Diluted)
$-3.40
QoQ Revenue Growth
-96.0%
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$12M
Total Liabilities
$14M
Stockholders' Equity
-$2M
Cash & Equivalents
$5M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$122,000
$73,000
+67.1%
Gross Profit
$122,000
$73,000
+67.1%
Operating Income
-$4M
-$4M
+7.8%
Net Income
-$4M
-$5M
+19.8%
← FY 2024
All Quarters
Q1 2025 →